Introduction Abbott agreed on Thursday, May 5th, to acquire St. Jude Medical in a cash and stock offer for c. $25bn. By combining, Abbott and St. Jude Medical will capture a larger position across the market for cardiovascular devices. This was the largest in a flurry of health-care deals announced Read more…
The post A new giant to save hearts: Abbott Laboratories acquires St. Jude Medical for 25bn appeared first on BSIC | Bocconi Students Investment Club.